Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Expand Energy Corporation Common Stock (EXE) vs Vaxcyte Inc. Common Stock (PCVX) Price & Performance

Expand Energy Corporation Common StockTrade
Vaxcyte Inc. Common StockTrade

Price performance (Past 24H)

Key statistics

Expand Energy Corporation Common Stock vs Vaxcyte Inc. Common Stock — how do they compare? Expand Energy Corporation Common Stock trades at $91.6 (market cap $21.38B), while Vaxcyte Inc. Common Stock trades at $67.37 (market cap $10.51B). The key difference: Expand Energy Corporation Common Stock is far larger — about 2× Vaxcyte Inc. Common Stock's market cap, and Expand Energy Corporation Common Stock pays a 2.49% dividend while Vaxcyte Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Expand Energy Corporation Common Stock for 0 Days and Vaxcyte Inc. Common Stock for 0 Days on average.

EXEPCVX
Market Cap
$21.38B$10.51B
Volume
3,544,5702,644,694
Sector
EnergyHealth
52-Week High
$122.89$73.82
52-Week Low
$84.09$40.32
Typical Hold Time
0 Days0 Days
Enterprise Value
$24.45B$9.14B
Dividend Yield
2.49%—

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

EXE
100% Buy0% Sell
Avg holding period · 0 Days
PCVX
100% Buy0% Sell
Avg holding period · 0 Days

Top news

Latest headlines on both assets

About Expand Energy Corporation Common Stock

Expand Energy Corporation is a US natural gas producer formed from the 2024 merger of Chesapeake Energy and Southwestern Energy, developing gas assets concentrated in the Appalachia and Haynesville basins.

Read more on EXE →

About Vaxcyte Inc. Common Stock

Vaxcyte, Inc. is a clinical-stage vaccine company that engineers protein-based vaccines to prevent bacterial diseases such as invasive pneumococcal disease, using its proprietary cell-free protein synthesis platform to develop candidates including the pneumococcal conjugate vaccines VAX-31 and VAX-24.

Read more on PCVX →